Kit C. B. Roes

4.5k citations

143 papers · 2.9k indexed · 1 hit paper · h-index 28

Statistics and Probability top 0.5%
Economics and Econometrics top 2%
Statistics, Probability and Uncertainty top 0.5%
Cardiology and Cardiovascular Medicine top 5%
Psychiatry and Mental health top 5%

Co-authors: Rolf H. H. Groenwold Arno W. Hoes Olaf H. Klungel Anthonius de Boer Karel G.M. Moons A. Rogier T. Donders Frank E. Harrell Ronald J. M. M. Does
Topics: Statistical Methods in Clinical Trials (43 papers)Health Systems, Economic Evaluations, Quality of Life (42 papers)Advanced Causal Inference Techniques (22 papers)
Cited by: Statistics and Probability Statistics, Probability and Uncertainty Economics and Econometrics
Journals: JAMA Circulation Nature Communications
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Kit C. B. Roes

134 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial

2023 77 citations Sander van Doorn, Melchior C. Nierman et al. profile →

Peers

Countries citing papers authored by Kit C. B. Roes

Since Specialization

Citations

This map shows the geographic impact of Kit C. B. Roes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kit C. B. Roes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kit C. B. Roes more than expected).

Fields of papers citing papers by Kit C. B. Roes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kit C. B. Roes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kit C. B. Roes. The network helps show where Kit C. B. Roes may publish in the future.

Co-authorship network of co-authors of Kit C. B. Roes

This figure shows the co-authorship network connecting the top 25 collaborators of Kit C. B. Roes. A scholar is included among the top collaborators of Kit C. B. Roes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kit C. B. Roes. Kit C. B. Roes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Evidence 2030 2025 ·Clinical Pharmacology & Therapeutics ·Peter Arlett,(unknown),Patrice Verpillat,Paolo Foggi,Ulla Liminga,Bruno Sepodes,(unknown),(unknown),Spiros Vamvakas,Kit C. B. Roes,Frank Pétavy,Steffen Thirstrup,María Jesús Lamas,Emer Cooke,Karl Broich	5
2	Artificial Intelligence in European Medicines Regulation: From Vision to Action. Harnessing the Capabilities of Artificial Intelligence for the Benefit of Public and Animal Health 2024 ·Clinical Pharmacology & Therapeutics ·(unknown),Peter Arlett,Kit C. B. Roes,Flora T. Musuamba,Gabriel Westman,(unknown),(unknown),(unknown),Iftekhar Khan,(unknown),Karl Broich,Emer Cooke	2
3	Combining evidence from clinical trials in conditional or accelerated approval 2023 ·Pharmaceutical Statistics ·Manja Deforth,(unknown),Kit C. B. Roes,Leonhard Held	2
4	Hybrid Controlled Clinical Trials Using Concurrent Registries in Amyotrophic Lateral Sclerosis: A Feasibility Study 2023 ·Clinical Pharmacology & Therapeutics ·Ruben P. A. van Eijk,Leonard H. van den Berg,Kit C. B. Roes,Lü Tian,Tze Leung Lai,Lorene M. Nelson,Chenyu Li,(unknown),(unknown),Ying Lü	2
5	Ethnic differences in response to atypical antipsychotics in patients with schizophrenia: individual patient data meta-analysis of randomised placebo-controlled registration trials submitted to the Dutch Medicines Evaluation Board 2023 ·BJPsych Open ·(unknown),(unknown),(unknown),(unknown),Wim van den Brink,Kit C. B. Roes,Lieuwe de Haan,Damiaan Denys,Jasper B. Zantvoord	0
6	Recurrent events analysis with piece-wise exponential additive mixed models 2022 ·Statistical Modelling ·Jordache Ramjith,Andreas Bender,Kit C. B. Roes,Marianne A. Jonker	5
7	Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studies 2022 ·Psychiatry Research ·(unknown),(unknown),Tamar Wohlfarth,Christine C. Gispen‐de Wied,Kit C. B. Roes,Wim van den Brink,Lieuwe de Haan,Damiaan Denys,Jasper B. Zantvoord	15
8	Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in Dilated Cardiomyopathy 2022 ·JACC. Cardiovascular imaging ·Anne G. Raafs,Jacqueline L Vos,Michiel T.H.M. Henkens,(unknown),Job A.J. Verdonschot,(unknown),Kit C. B. Roes,Suzanne C. Gerretsen,(unknown),Mark R. Hazebroek,Robin Nijveldt,Stéphane Heymans	52
9	Medical Specialists' Perspectives on the Influence of Electronic Medical Record Use on the Quality of Hospital Care: Semistructured Interview Study 2021 ·JMIR Human Factors ·(unknown),A.J.P. Schrijvers,Albert Boonstra,Kit C. B. Roes	6
10	In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials 2021 ·Nature Communications ·(unknown),Toni Lassila,(unknown),(unknown),Kit C. B. Roes,James V. Byrne,Alejandro F. Frangi	48
11	The SNAP Trial: 2-Year Results of a Double-Blind Multicenter Randomized Controlled Trial of a Silicon Nitride Versus a PEEK Cage in Patients After Lumbar Fusion Surgery 2021 ·Global Spine Journal ·(unknown),F. Cumhur Öner,Mark P. Arts,(unknown),Kit C. B. Roes,Arthur de Gast,Steven M. van Gaalen	10
12	Efficacy gap between phase II and subsequent phase III studies in oncology 2020 ·British Journal of Clinical Pharmacology ·Rick A. Vreman,Svetlana V. Belitser,(unknown),Anke M. Hövels,Wim Goettsch,Kit C. B. Roes,Hubert G.M. Leufkens,Aukje K. Mantel‐Teeuwisse	10
13	Beyond “Intent‐to‐treat” and “Per protocol”: Improving assessment of treatment effects in clinical trials through the specification of an estimand 2019 ·British Journal of Clinical Pharmacology ·Frank Pétavy,Lorenzo Guizzaro,(unknown),Steven Teerenstra,Kit C. B. Roes	14
14	Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial 2019 ·BMJ Open ·(unknown),Sander van Doorn,Arno W. Hoes,Melchior C. Nierman,(unknown),Huiberdina L. Koek,Martin E W Hemels,Menno V. Huisman,Kit C. B. Roes,(unknown),(unknown),Frans H. Rutten,Geert‐Jan Geersing	11
15	Multimodal, automated detection of nocturnal motor seizures at home: Is a reliable seizure detector feasible? 2017 ·Epilepsia Open ·Judith van Andel,Constantin Ungureanu,Johan Arends,Francis Tan,Johannes van Dijk,George Petkov,Stiliyan Kalitzin,(unknown),Al de Weerd,(unknown),Roland D. Thijs,Ghislaine J. M. W. van Thiel,Kit C. B. Roes,Frans S. S. Leijten	47
16	Validation of multisource electronic health record data: an application to blood transfusion data 2017 ·BMC Medical Informatics and Decision Making ·(unknown),Martine C. de Bruijne,Peter Kemper,Maria M.W. Koopman,Jan M.M. Rondeel,Anja Leyte,Hendrik Koffijberg,Mart P. Janssen,Kit C. B. Roes	10
17	[A proactive approach to risks: from responding tot leading]. 2015 ·PubMed ·Marieke Zegers,Gijs Hesselink,Kit C. B. Roes,Wytske W. Geense,Hub Wollersheim	1
18	Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: A four-week, randomized, double-blinded, placebo-controlled study 2014 ·European Neuropsychopharmacology ·Chong Guan Ng,Marco P. Boks,Kit C. B. Roes,Nor Zuraida Zainal,Ahmad Hatim Sulaiman,Tan Seng Beng,Niek J. de Wit	37
19	Justification of exclusion criteria was underreported in a review of cardiovascular trials 2014 ·Journal of Clinical Epidemiology ·Amand F. Schmidt,Rolf H. H. Groenwold,Johannes J. M. van Delden,Yuri van der Does,Olaf H. Klungel,Kit C. B. Roes,Arno W. Hoes,Rieke van der Graaf	22
20	Statistical Methods to Monitor Risk Factors in a Clinical Database 2013 ·Circulation Cardiovascular Quality and Outcomes ·Sabrina Siregar,Kit C. B. Roes,Albert H.M. van Straten,Michiel L. Bots,Yolanda van der Graaf,Lex A. van Herwerden,Rolf H. H. Groenwold	4

About Kit C. B. Roes

Kit C. B. Roes is a scholar working on Statistics and Probability, Statistics, Probability and Uncertainty and Economics and Econometrics, having authored 143 papers that have together received 2.9k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (43 papers), Health Systems, Economic Evaluations, Quality of Life (42 papers) and Advanced Causal Inference Techniques (22 papers). The work is most often cited by research in Statistics and Probability (645 citations), Statistics, Probability and Uncertainty (377 citations) and Economics and Econometrics (529 citations). Kit C. B. Roes has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Rolf H. H. Groenwold, Arno W. Hoes, Olaf H. Klungel, Anthonius de Boer, Karel G.M. Moons, A. Rogier T. Donders, Frank E. Harrell, Ronald J. M. M. Does, Ingeborg van der Tweel and Stavros Nikolakopoulos. Their work appears in journals such as JAMA, Circulation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact